Home > Insider Trading > Filing (0001214659-21-006408)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1293310	Humanigen Inc	HGEN	Pharmaceutical Preparations (2834)	770557236

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1600814	P. Edward Jordan	C/O Humanigen, Inc. 533 Airport Blvd., Suite 400 Burlingame CA 94010	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-08	14,700	$9.65	14,700	No	4	M	Direct
Common Stock	Disposition	2021-06-08	14,700	$20.08	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-06-08	14,700	$0.00	14,700	$9.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
73,500	2020-12-31	2030-09-18	No	4	M	Direct

Footnotes

On September 18, 2020, Mr. Jordan was granted an option to purchase 88,200 shares of the Company's common stock, which vests in 12 ratable quarterly installments commencing December 31, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.21, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).